Last update May 4, 2022
Very Low Risk
Sulbactam is a penicillanic acid sulfone with beta-lactamase inhibitory properties. It is given with ampicillin in the treatment of infections in which beta-lactamase production is suspected. Oral and parenteral administration every 4 to 6 hours.
Both ampicillin and sulbactam are excreted in breast milk in insignificant amounts (Campbell AC 1991, Matheson I 1988, Nau H 1987, Foulds G 1985, Matsuda S 1985) and no side effects have been observed in infants whose mothers were taking it. (Rowe 2013, AAP 2001)
Follow-up for appearance of diarrhea since alteration of intestinal flora can occur (Chin KG 2000). The possibility of transient gastroenteritis due to alteration of the intestinal flora in infants whose mothers take antibiotics should be taken into account. (Benyamini 2005, Ito 1993, Kafetzis 1981)
We do not have alternatives for Ampicillin - Sulbactam since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2012 of United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM